Powered by: Motilal Oswal
2025-07-14 08:52:52 am | Source: ARETE Securities Ltd
Stock Insights : DLF Ltd, Lloyds Enterprises Ltd, Zydus Lifesciences Ltd, RITES Ltd, Kamat Hotels Ltd - ARETE Securities Ltd
Stock Insights : DLF Ltd, Lloyds Enterprises Ltd, Zydus Lifesciences Ltd, RITES Ltd, Kamat Hotels Ltd - ARETE Securities Ltd

Market Updates

The markets are expected to open marginally lower today as trends in GIFT NIFTY indicate a negative start for the broader index after NIFTY closed 205 points lower at 25,149 on Friday.

DLF

The company received Rs.100 crore as first tranche under arbitration settlement with TFDRL and remaining amount is secured via 1.5 lakh sq ft mortgage.

HFCL

The company approved Rs.125.55 crore capex to expand IBR cable capacity from 1.73 mfkm to 19.01 mfkm across Hyderabad and Goa by June 2026.

HUDCO

The company signed a non-binding MoU with MPUDCL to provide Rs.1,00,000 crore financial assistance over 5 years for housing and infrastructure projects.

Kamat Hotels

The company signed an agreement to manage a second luxury hotel in Rishikesh with 44 rooms under The Orchid brand.

Lloyds Enterprises

The company’s subsidiary LRDL signed an MOU to acquire 51% in CLPL for ?60 crore and extend Rs.242 crore debt to develop 99-acre Taloja logistics park.

NCC

The company received Rs.2,269 crore LOA from MMRDA for a 24-month Mumbai Metro Line 6 Package-1 project including signalling, telecom, and rolling stock.

RITES

The company received Rs.46.82 crore turnkey order (36-month duration) from DCTE Karnataka for college construction and renovation under PM-USHA scheme.

RVNL

The company received Rs.213.22 crore LOA from South Central Railway for 24-month OHE upgradation in Duvvada–Rajahmundry & Samalkot–Kakinada Port section.

Tata Elxsi

The company signed a MoU with Synopsys to jointly offer advanced vECU and digital twin solutions for software-defined vehicle development and validation.

Titagarh Rail Systems

The company signed a 99-year lease with WB Govt for 40.009 acres at Rs.126.63 crore to expand metro, Vande Bharat and defence rolling stock infra with testing and commissioning facilities at Uttarpara.

Wockhardt

The company exited the US generics segment after $8 million FY25 loss, filing Chapter 7 for 2 US units to focus on antibiotics and insulin.

Zydus Lifesciences

The company’s US subsidiary ZPUI incorporated Zylidac Bio LLC in the US to acquire biologics manufacturing assets of Agenus.

 

Please refer disclaimer at http://www.aretesecurities.com/

SEBI Regn. No.: INM0000127

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here